InvestorsHub Logo
Followers 34
Posts 6200
Boards Moderated 0
Alias Born 07/05/2004

Re: None

Wednesday, 10/18/2017 11:06:58 PM

Wednesday, October 18, 2017 11:06:58 PM

Post# of 12418
I wonder who they are going to do this with...hope it's a big name company..

3. Ischemic Stroke Repair (anticipated start 4th quarter 2017)

Ischemic Stroke is usually associated with severe disabilities, high recurrence rate and other poor outcomes. Currently, there are no long-term effective treatments for stroke. Cell therapies have been explored previously. However, the therapeutic outcomes are often limited by poor survival of transplanted cells, difficult delivery, uncontrolled cell differentiation, ineffective engraftment with host tissues and non-sustained delivery of growth factors.

We will be testing to demonstrate that the AAGP™ molecule suppresses the inflammatory attack caused by ischemic stroke thereby preventing any long term damage to the humans..